Skip to content

Clinical trials

Terminated Phase 2 Hypersensitivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Phase 2 Status: Terminated Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20063
20081
20092
20121
20131
20141
20161
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aimmune Therapeutics, Inc.1
Allergy Therapeutics1
AstraZeneca1
Centre Jean Perrin1
Dynavax Technologies Corporation1
Genentech, Inc.1
Koffler Vision Group1
Laboratorios Leti, S.L.1
Massachusetts General Hospital1
Mogens Bove1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity13
Asthma2
Rhinitis, Allergic, Seasonal2
Breast Neoplasms1
Conjunctivitis1
Conjunctivitis, Allergic1
Eosinophilic Esophagitis1
Esophagitis1
Food Hypersensitivity1
Hypersensitivity, Immediate1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.